Healt


 Zooming Lens on Neuren’s Drug Candidate, NNZ-2591

Zooming Lens on Neuren’s Drug Candidate, NNZ-2591

August 27, 2019 01:10 PM AEST| By Team Kalkine Media

Australian-headquartered biopharmaceutical company, Neuren Pharmaceuticals Limited (ASX: NEU) develops a range of novel therapies for treating neurodevelopmental disorders with a high unmet medical need, using artificial analogs of neurotrophic pepti...

 ResApp Health Acquires CE Mark Certification For World’s First Smartphone-Based Tool For Acute Respiratory Disease

ResApp Health Acquires CE Mark Certification For World’s First Smartphone-Based Tool For Acute Respiratory Disease

August 26, 2019 10:02 PM AEST| By Team Kalkine Media

ResApp Health Limited (ASX: RAP), is a prime healthcare company headquartered in Brisbane, Australia that creates clinically validated, regulatory-cleared, smartphone applications based digital tools to diagnose and manage acute respiratory diseases....

 What’s brewing up in Pharmaceutical space: MYX, MXC, CGB, OSL

What’s brewing up in Pharmaceutical space: MYX, MXC, CGB, OSL

August 26, 2019 06:57 PM AEST| By Team Kalkine Media

During the ongoing Earnings season, few pharma companies have reported decent sets of numbers, while most of the companies have posted quarterly loss added by higher R&D costs and higher capital expenditure due to establishment of new facilities....

 Noxopharm pre-clinical evidence confirms Veyonda® abscopal effect; NOX completes three years on ASX

Noxopharm pre-clinical evidence confirms Veyonda® abscopal effect; NOX completes three years on ASX

August 26, 2019 02:37 PM AEST| By Team Kalkine Media

On 21 August 2019, clinical-stage drug development company Noxopharm Limited (ASX: NOX) pre-clinical evidence confirmed that its lead drug candidate Veyonda® has the potential to produce off-target responses known as an abscopal effect. The comp...

 Is Healthcare Sector Getting Hot – HLS, NAN, SNZ, PME

Is Healthcare Sector Getting Hot – HLS, NAN, SNZ, PME

August 24, 2019 08:15 AM AEST| By Team Kalkine Media

Despite being one of the best healthcare systems in the world, Australia?s Healthcare sector has been victim to a number of challenges including rising chronic diseases, increasing demand of new treatments, more hospital beds and the ageing populatio...

 New Generation Healthcare Stocks To Look For- RAC, BOT, AVE, JHL, GLH, LSH

New Generation Healthcare Stocks To Look For- RAC, BOT, AVE, JHL, GLH, LSH

August 21, 2019 09:40 PM AEST| By Team Kalkine Media

Digital healthcare service has evolved as one of the fastest-growing industries in the modern era. Introduction of technology in medical science has emerged as one of the biggest blessings for human. Digitally connected network systems have helped me...

 SUDA Makes Speedy Progress with its Robust Product Pipeline

SUDA Makes Speedy Progress with its Robust Product Pipeline

August 21, 2019 01:28 PM AEST| By Team Kalkine Media

SUDA Pharmaceuticals Ltd (ASX: SUD) is transforming the drug delivery technology to improve the lifestyle and health of the global community by offering innovative and high-quality oro-mucosal spray pharmaceutical products to aid in the treatment of...

 A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Market

A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Market

August 20, 2019 04:36 PM AEST| By Team Kalkine Media

Imugene Limited (ASX: IMU) is a clinical stage biotechnology company that focuses on the development of immunotherapies that have the potential to enable a patient?s immune system to recognise and destroy cancer cells. The company is focused on targe...

 A Lens On Noxopharm’s June 2019 Quarterly Results

A Lens On Noxopharm’s June 2019 Quarterly Results

August 19, 2019 03:16 PM AEST| By Team Kalkine Media

Noxopharm Limited (ASX: NOX) has recently released its quarterly report for the three months ended 30 June 2019, covering updates from both Noxopharm and its majority-owned subsidiary, Nyrada Inc. Let us travel through the chief developments of the...

 Players In Healthcare Space – MXC, OCC, CPH, ZLD and OVN

Players In Healthcare Space – MXC, OCC, CPH, ZLD and OVN

August 18, 2019 08:00 AM AEST| By Team Kalkine Media

The healthcare industry of Australia is a key contributor in developing the economy. The companies who are in this industry, have to update them with the new medicine for the treatment of the diseases. The healthcare space of Australia is primarily r...

 5 Healthcare Stocks With Some Fizz – AGH, MYX, PAR, SPL, MVP

5 Healthcare Stocks With Some Fizz – AGH, MYX, PAR, SPL, MVP

August 17, 2019 08:15 AM AEST| By Team Kalkine Media

The Australian health system is tagged amongst the best in the world and focusses on providing safe and affordable health care for all the Australians. The federal, state and local government jointly run the system to ensure its adherence. As per the...

 Health Care & Later Stage Cycles: HLS, NAN & CUV

Health Care & Later Stage Cycles: HLS, NAN & CUV

August 16, 2019 10:25 PM AEST| By Team Kalkine Media

In this article, we discuss three stocks from the health care sector in Australia. These stocks are recognised in the benchmark - S&P/ASX 200 index along with the S&P/ASX 200 Health Care (Sector) index. Besides, the market capitalisation of e...

 Cochlear Limited Unveiled FY19 Results; Reported 7% Revenue Growth

Cochlear Limited Unveiled FY19 Results; Reported 7% Revenue Growth

August 16, 2019 06:56 PM AEST| By Team Kalkine Media

Implantable hearing solutions provider, Cochlear Limited (ASX: COH) has reported a sales revenue growth of 7% in FY19. The company also earned a net profit (including the revaluation of innovation fund) of $276.7 million in FY19, an increase of 13% a...

 4 Healthcare Stocks Trading High On ASX- CSL, RMD, RHC, SHL

4 Healthcare Stocks Trading High On ASX- CSL, RMD, RHC, SHL

August 14, 2019 10:28 PM AEST| By Team Kalkine Media

The below mentioned healthcare stocks are trading close to their 52 weeks high prices. Let?s take a quick look at the recent financial and operational performances of these stocks. CSL Limited (ASX: CSL) Global biotechnology company, CSL Limited (...

 SUDA’s Science Advisory Board Member, Dr Richard Franklin Joins as Project Director of Anagrelide Project

SUDA’s Science Advisory Board Member, Dr Richard Franklin Joins as Project Director of Anagrelide Project

August 14, 2019 12:51 PM AEST| By Team Kalkine Media

SUDA Pharmaceuticals Ltd (ASX: SUD), an oro-mucosal drug delivery company headquartered in Perth, focusses on developing low-risk oral sprays using its proprietary OroMist? oro-mucosal technology to reformulate the existing medications. The OroMist?...

 Imugene Goes Great Guns with Strong Management Team

Imugene Goes Great Guns with Strong Management Team

August 14, 2019 12:45 PM AEST| By Team Kalkine Media

Imugene Limited (ASX: IMU), an Australian-headquartered clinical-stage immuno-oncology company, focusses on the development of emerging immunotherapies to enhance the efficacy of cancer treatments. The company utilises its unique platform technology...

 Highlights on Health-Related Space from 5 ASX Companies - MXC, NHL, KZA, IHL and AFA  

Highlights on Health-Related Space from 5 ASX Companies - MXC, NHL, KZA, IHL and AFA  

August 13, 2019 05:55 PM AEST| By Team Kalkine Media

Australia has a well-regulated and high-quality health sector, while its medical research and healthcare infrastructure is of world class. Over the years, the health and medical industry in the country has grown at a rapid pace in terms of both size...

 2 Healthcare Stocks To Look At - HMD, MSB

2 Healthcare Stocks To Look At - HMD, MSB

August 12, 2019 11:14 PM AEST| By Team Kalkine Media

Australia?s Healthcare Sector is recognised as one the best in the world with significant advances in technology that help provide better ways of delivering healthcare services. However, the sector is also prone to a number of challenges like in othe...

 Prescient’s Leaders Have A Rich History Of Taking Drugs From Bench To Bedside

Prescient’s Leaders Have A Rich History Of Taking Drugs From Bench To Bedside

August 12, 2019 03:35 PM AEST| By Team Kalkine Media

Prescient Therapeutics Limited (ASX: PTX) is an Australian clinical stage oncology company that is into the development of personalised medicines for the treatment of multiple cancers. The company aims to develop novel drugs that work on the mechani...

 Are you aware of ALS Limited’s Recent Acquisition and Starpharma’s Regulatory Grant?

Are you aware of ALS Limited’s Recent Acquisition and Starpharma’s Regulatory Grant?

August 09, 2019 02:11 PM AEST| By Team Kalkine Media

August 2019 is proving to be much more than just a reporting season. Along with the earning releases and outlook notifications, the companies have been hinting towards the various feathers in their caps. Amid these announcements came an update from t...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.